Richmond Pharmacology is proud to announce that it will be hosting the AHPPI Winter Meeting early next month.

Posted:
7
December 2009

Richmond Pharmacology is proud to announce that it will be hosting the AHPPI Winter Meeting early next month.The AHPPI is an informal cross-industry discussion group whose purpose is to address issues facing those involved in early phase drug development and to educate members through directed symposia at each of its 2 meetings per year.The Association has been in existence for over nearly 2 decades and has forged links with both other scientific societies with similar interests and with professional bodies such as the ABPI and ICR.   For several years, the association has been organising joint biannual meetings with the clinical section of the British Pharmacological Society , all of which have been very successful and will continue in the future.This year s AHPPI Annual Winter meeting will be hosted at St George s Hospital, University of London, Tooting and will take place on 4th February 2010. We kindly invite all members of the AHPPI as well as those who are not members and keen to attend, to join us on the day.The meeting has recently been awarded 3 CPD points by the Faculty of Pharmaceutical Physicians.The topic of discussion will be �Current Advances in the Development of Vaccines and Biopharmaceuticals: A Challenge not be Sneezed at?� and there is an exciting list of key speakers already lined up for the day, namely;�    Professor David Lewis, St George�s Vaccine Institute�    Dr Afshan Ahmad, Vaccine Research International�    Dr Simon Beddows, Health Protection Agency�    Dr Azharul Mannan, Sanofi Pasteur MSD�    Professor Geoff Hale, BioAnaLab�    Professor John Oxford, Retroscreen Virology Ltd.�    Andrew Nolan, QuintilesFor further details for what�s in store for the day, please click here to view the meeting agenda.If you would like to register for this meeting; please complete our online registration form.If you would like to request more information, please email us at info@richmondpharmacology.com or complete our online enquiry form.Registrations for AHPPI members: �20.00Registrations for non-members: �50.00

Richmond Pharmacology is proud to announce that it will be hosting the AHPPI Winter Meeting early next year.

Latest news

Upcoming Event

EUFEMED, 3rd Annual Conference, 28-30 April 2021

28-30 April 2021
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
View event

Richmond Pharmacology listed in the Alantra Pharma Fast 50

July 13, 2021
Richmond has been included in a top 50 list of the UK’s fastest-growing, privately-owned pharmaceutical businesses. 
Read more

Richmond Pharmacology listed in the J.P. Morgan Top 200 Female Powered Businesses

June 29, 2021
J.P. Morgan has identified Richmond Pharmacology as a high-growth female-powered business in its annual 'Top 200 Female Powered Businesses' list 2021.
Read more

CRISPR-Cas9 in-vivo gene editing shows reduction in TTR after a single dose

June 29, 2021
Data produced through Intellia Therapeutic’s NTLA-2001 FIH clinical trial, conducted at Richmond Pharmacology, indicates a reduction in the faulty TTR protein after a single infusion. Results were presented by Professor Julian Gillmore at this year’s Peripheral Nerve Society Annual Meeting.
Read more